ArticleElectrophoresis2026
Optimized iCIEF Fractionation Enables Deep Profiling of Antibody Drug Conjugate Charge Heterogeneity.
Article in Electrophoresis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Antibody drug conjugates (ADCs) are a novel class of therapeutic drugs that combine selectivity of an antibody moiety with the cell killing potency of cytotoxic agent. ADCs are complex molecules, and their charge variants are one of the important critical quality attributes (CQAs) that need to be monitored throughout the drug development process. Imaged capillary isoelectric focusing (iCIEF) is considered a gold standard in charge variant analysis due to its short analysis time and ease of use. For comprehensive analysis, iCIEF fractionation is a newly developed technique that can be used to enable LC-MS characterization of charge variants. Here, we describe method development for an iCIEF fractionation system, as well as further characterization using LC-MS. Fractionation conditions were optimized to provide stabilized mobilization after separation. Fractions were collected with the optimized method, and native SEC-MS results showed that fractionation enabled detection of species previously undetectable. Further mass spectrometric analysis revealed the major posttranslational modifications (PTMs) and drug load distributions for both light and heavy chains. The results indicate that iCIEF fraction collection enables a deeper understanding of ADC charge variants and will be further useful for studying other complex biomolecules.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.